文献速递泌尿生殖MR

基于双参数MRI影像组学特征鉴别前列腺良恶性病变

Using biparametric MRI radiomics signature to differentiate between benign and malignant prostate lesions.
PubMed 文献 · Eur J Radiol · 2019-02-25

研究纳入2013年1月至2016年11月行bp-MRI后接受病理检查的331例患者,基于T2WI、DWI及ADC提取影像组学特征,用232例构建、99例验证预测模型。验证队列中Bp signature的AUC为0.92,高于T2WI的0.81、DWI的0.77和ADC的0.89,也高于临床模型0.73;联合临床因素的个体预测模型AUC为0.93。

要点

  • Bp signature在验证队列AUC为0.92,优于单一序列(T2WI 0.81、DWI 0.77、ADC 0.89)。
  • 仅用临床独立危险因素的临床模型AUC为0.73,低于Bp signature。
  • 联合Bp signature与临床因素的个体预测模型AUC达0.93。

核心结论

  • 基于bp-MRI的Bp signature鉴别效能优于任一单一成像序列;联合影像组学特征与临床因素的个体预测模型术前诊断表现更好,可能有助于临床个体化治疗。

研究设计与样本

  • 研究纳入331例在病理检查前接受bp-MRI的患者,收集时间为2013年1月至2016年11月。

诊断标准与关键数值

  • 验证队列中Bp signature的AUC为0.92,T2WI为0.81,DWI为0.77,ADC为0.89。
  • 临床模型基于有统计学意义(P < 0.05)的独立临床危险因素构建,AUC为0.73。
  • 联合Bp signature与临床因素的个体预测模型AUC为0.93。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the efficiency of radiomics signature in discriminating between benign and malignant prostate lesions with similar biparametric magnetic resonance imaging (bp-MRI) findings.

EXPERIMENTAL DESIGN: Our study consisted of 331 patients underwent bp-MRI before pathological examination from January 2013 to November 2016. Radiomics features were extracted from peripheral zone (PZ), transition zone (TZ), and lesion areas segmented on images obtained by T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and its derivative apparent-diffusion coefficient (ADC) imaging. The individual prediction model, built using the clinical data and biparametric MRI features (Bp signature), was prepared using data of 232 patients and validated using data of 99 patients. The predictive performance was calculated and demonstrated using receiver operating characteristic (ROC) curves, calibration curves, and decision curves.

RESULTS: The Bp signature, based on the six selected radiomics features of bp-MRI, showed better discrimination in the validation cohort (area under the curve [AUC], 0.92) than on each subcategory images (AUC, 0.81 on T2WI; AUC, 0.77 on DWI; AUC, 0.89 on ADC). The differential diagnostic efficiency was poorer with the clinical model (AUC, 0.73), built using the selected independent clinical risk factors with statistical significance (P < 0.05), than with the Bp signature. Discrimination efficiency improved when including the Bp signature and clinical factors [i.e., the individual prediction model (AUC, 0.93)].

CONCLUSION: The Bp signature, based on bp-MRI, performed better than each single imaging modality. The individual prediction model including the radiomics signatures and clinical factors showed better preoperative diagnostic performance, which could contribute to clinical individualized treatment.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Xu M, Fang M, Zou J, et al. Using biparametric MRI radiomics signature to differentiate between benign and malignant prostate lesions. Eur J Radiol. 2019. PMID: 31005174. doi:10.1016/j.ejrad.2019.02.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。